Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 4,000 shares at $84.81 ($340K) on 2018-05-11, disclosed to the SEC on 2018-05-15.
Open-market sale of $340k AGIO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.81 | 840 | $71K | 21.0% |
| 2 | $84.81 | 840 | $71K | 21.0% |
| 3 | $85.14 | 1,160 | $99K | 29.0% |
| 4 | $85.14 | 1,160 | $99K | 29.0% |
| Total | $85.00 avg | 4,000 | $340K | 100% |
| Filing → |
| AGIO | SELL | 2021-06-11 | $3.4M | — | Filing → |
| AGIO | SELL | 2021-06-09 | $1.3M | — | Filing → |
| AGIO | SELL | 2021-04-21 | $1.9M | — | Filing → |